Article (Scientific journals)
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system
Ziermann, Rainer; Celis, Linda; Derdelinckx, Inge et al.
2004In Journal of Clinical Virology, 31 (Suppl. 1), p. 7-S15
Peer Reviewed verified by ORBi


Full Text
Ziermann Virologic therapy 2004.pdf
Author postprint (256.58 kB)

All documents in ORBi are protected by a user license.

Send to


Keywords :
HIV-1; antiretroviral drug resistance; interpretation algorithm; line probe assay
Abstract :
[en] Background: Resistance testing is increasingly accepted as a tool in guiding the selection of human immunodeficiency virus type 1 (HIV-1) antiretroviral therapy in HIV-1 infected individuals who fail their current regimen. Objectives: To descriptively compare the correlation between virologic treatment response and results using three genotypic HIV-1 drug resistance interpretation systems: the VERSANT(R) HIV-1 Resistance Assay (LiPA) system and two sequence-based interpretation systems. Study design: Specimens from 213 HIV-1-infected subjects, either starting (n = 104) or switching to (n = 109) a regimen of three or four antiretroviral drugs, were collected retrospectively at baseline and after 3 months of uninterrupted therapy. The correlation between viral load change and the number of predicted active drugs in the treatment regimen was assessed. An interpretation algorithm was recently developed to process VERSANT(R) HIV-1 Resistance Assay (LiPA) data. The number of active drugs predicted using this algorithm was rank correlated with the viral load change over a 3-month treatment period. For comparison, a similar calculation was made using two sequence-based algorithms (REGA version 5.5 and VGI GuideLines(TM) Rules 4.0), both applied on the same sequences. Results: Statistically significant (p < 0.05) correlation coefficients for each of the three HIV-1 drug resistance interpretation systems were observed in the treatment-experienced subjects on a 3-drug regimen (-0.39, -0.38, and -0.42, respectively) as well as on a 4-drug regimen (-0.33, -0.31, and -0.37, respectively). However, no significant correlation was observed in treatment-naive subjects, probably due to the very low frequency of drug resistance in these subjects. Conclusion: All three genotypic drug resistance interpretation systems (LiPA version 1, REGA version 5.5, and VGI GuideLines(TM) Rules 4.0) were statistically significantly correlated with virologic therapy response as measured by viral load testing. (C) 2004 Elsevier B.V. All rights reserved.
Disciplines :
Immunology & infectious disease
Author, co-author :
Ziermann, Rainer
Celis, Linda
Derdelinckx, Inge
Lambert, Christine
Veeck, Jurgen
Rizzo, Maria G.
Vanderborght, Bart
Zissis, Georges
Clumeck, Nathan
Fransen, Katrien
Vaira, Dolorès ;  Centre Hospitalier Universitaire de Liège - CHU > Immuno-hématologie
Hendricks, David
Van Laethem, Kristel
Vandamme, Anne-Mieke
Schmit, Jean-Claude
Knechten, Heribert
De Luca, Andrea
Louwagie, Joost
Segers, Pascale
De Boeck, Kristel
Pottel, Hans
De Brauwer, Annelies
Hulstaert, Frank
More authors (13 more) Less
Language :
Title :
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system
Publication date :
December 2004
Journal title :
Journal of Clinical Virology
Publisher :
Elsevier Science Bv, Amsterdam, Netherlands
Volume :
Issue :
Suppl. 1
Pages :
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 26 February 2010


Number of views
78 (3 by ULiège)
Number of downloads
208 (1 by ULiège)

Scopus citations®
Scopus citations®
without self-citations


Similar publications

Contact ORBi